113 related articles for article (PubMed ID: 17099625)
21. Therapeutic research in untreated acute promyelocytic leukemia.
Estey E
Leukemia; 2005 Jun; 19(6):913-5. PubMed ID: 15843820
[No Abstract] [Full Text] [Related]
22. Silymarine during maintenance therapy of acute promyelocytic leukemia.
Invernizzi R; Bernuzzi S; Ciani D; Ascari E
Haematologica; 1993; 78(5):340-1. PubMed ID: 8314167
[No Abstract] [Full Text] [Related]
23. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
24. Tailoring treatment strategy for acute promyelocytic leukemia in low-income countries.
Rizzari C; Biondi A
Pediatr Blood Cancer; 2009 Sep; 53(3):303-5. PubMed ID: 19544375
[No Abstract] [Full Text] [Related]
25. Acute promyelocytic leukaemia presenting with a myeloid sarcoma of the tongue.
Mohamedbhai S; Pule M; Conn B; Hopper C; Ramsay A; Khwaja A
Br J Haematol; 2008 May; 141(5):565. PubMed ID: 18373707
[No Abstract] [Full Text] [Related]
26. Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report.
Ciccone M; Rigolin GM; Viglione GM; Borrelli M; Serino ML; Cuneo A
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):721-3. PubMed ID: 18832917
[TBL] [Abstract][Full Text] [Related]
27. Therapy for elderly patients with acute myeloid leukemia: a problem in search of solutions.
Kantarjian HM
Cancer; 2007 Mar; 109(6):1007-10. PubMed ID: 17279580
[No Abstract] [Full Text] [Related]
28. Curing acute myelogenous leukemia: still a major challenge.
Smith BD; Karp JE
Leuk Res; 2005 Jun; 29(6):607-8. PubMed ID: 15863198
[No Abstract] [Full Text] [Related]
29. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
Ma J
Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
[No Abstract] [Full Text] [Related]
30. [Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children].
Chen J; Gu LJ; Tang JY; Xue HL; Pan C; Ye QD; Jiang H; Dong L; Zhou M; Wang YP
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):329-32. PubMed ID: 18554461
[TBL] [Abstract][Full Text] [Related]
31. [Survival in adults with acute myelogenous leukemia].
Tangen JM; Fløisand Y; Foss-Abrahamsen J; Haukås E; Naess IA; Skjelbakken T
Tidsskr Nor Laegeforen; 2008 May; 128(10):1164-7. PubMed ID: 18480864
[TBL] [Abstract][Full Text] [Related]
32. Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia.
Sanz MA; Martin G; Rayón C; Debén G; Tormo M; Díaz-Mediavilla J; Esteve J; González-San Miguel JD;
Leukemia; 2001 Dec; 15(12):1999-2002. PubMed ID: 11753627
[No Abstract] [Full Text] [Related]
33. Secondary chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia.
Jeddi R; Gouider E; Benneji H; Mnif S; Ben Abid H; Belhadjali Z; Meddeb B
Pathol Biol (Paris); 2008 May; 56(3):162-3. PubMed ID: 18178033
[TBL] [Abstract][Full Text] [Related]
34. What is the role of arsenic in newly diagnosed APL?
Tallman MS
Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acute myeloid leukemia in older patients.
Roboz GJ
Expert Rev Anticancer Ther; 2007 Mar; 7(3):285-95. PubMed ID: 17338649
[TBL] [Abstract][Full Text] [Related]
36. Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
Pigneux A; Perreau V; Jourdan E; Vey N; Dastugue N; Huguet F; Sotto JJ; Salmi LR; Ifrah N; Reiffers J
Haematologica; 2007 Oct; 92(10):1327-34. PubMed ID: 18024370
[TBL] [Abstract][Full Text] [Related]
37. Interstitial granulomatous dermatitis secondary to acute promyelocytic leukemia.
Swing DC; Sheehan DJ; Sangüeza OP; Woodruff RW
Am J Dermatopathol; 2008 Apr; 30(2):197-9. PubMed ID: 18360133
[No Abstract] [Full Text] [Related]
38. Improved outcome for Chinese children with acute promyelocytic leukemia: a comparison of two protocols.
Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
Pediatr Blood Cancer; 2009 Sep; 53(3):325-8. PubMed ID: 19422024
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.
Metzeler KH; Boeck S; Christ B; Hausmann A; Stemmler HJ; Parhofer KG; Ostermann H; Hiddemann W; Braess J
Leuk Res; 2009 Jul; 33(7):e69-72. PubMed ID: 19230970
[No Abstract] [Full Text] [Related]
40. Paraneoplastic Sweet's syndrome and the pathergy phenomenon.
Awan F; Hamadani M; Devine S
Ann Hematol; 2007 Aug; 86(8):613-4. PubMed ID: 17468870
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
